Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Book your hotel in Manhattan online.
Popular Articles

Innovative Educational Program Designed To Improve Care For Growing Number Of Older Adults Expands To Three More Schools
A highly successful and innovative training program that prepares chief residents at medical schools to diagnose and treat health problems common to older adults -- and to prepare the medical students and residents who they help train to do the same -- will include three additional medical schools, the Association of Directors of Geriatric Academic Programs (ADGAP) has announced.

Buy lamisil to treat nail fungus.
British Medical Association Voices Concerns About Plans For London Hospitals
Plans to replace London"s District General Hospitals with new local hospitals providing fewer services carry clinical risks and need more thought, the BMA says today.
News of the day
Bisphenol A Exposure Increases Risk Of Abnormal Heart Rhythms In Female Rodents
The chemical bisphenol A, commonly found in many plastic household items, has been linked to yet another health problem in animals - an increased frequency of arrhythmias, or heartbeat irregularities, a new study found. The results, seen only in females, will be presented Saturday at The Endocrine Society"s 91st Annual Meeting in Washington, D.C.
Diagnostics

Medtronic And Abbott Laboratories Resolve Global Vascular Patent Disputes

Medtronic, Inc. (NYSE: MDT) announced global resolution of all outstanding intellectual property litigation with Abbott Laboratories. Terms of the agreement stipulate that neither party will sue each other in the field of coronary stent and stent delivery systems for a period of at least 10 years, subject to certain conditions. The agreement includes a $400 million settlement payment to be made to Abbott and also results in a $42 million success payment to evYsio Medical Devices, LLC, as part of a Medtronic sublicense to Abbott of the evYsio stent design technology. In connection with the settlement, Medtronic expects to report in its first quarter financial results a special charge to be calculated in accordance with generally accepted accounting principles. Following the resolution of these disputes with Abbott, Medtronic has now resolved or settled substantially all intellectual property litigation affecting the stent design and stent delivery systems of its bare metal and drug-eluting stent franchise. As a result, Medtronic will now focus more res on efforts to improve health care for patients with vascular disease. Medtronic


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009